- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 56
GBT reaches unicorn status with $150m series A
Fresh funding for the EV battery company comes as Chinese automotive players are ramping up mobility investment efforts.
May 6, 2022Daily Deal Round Up: May 5, 2022
The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.
May 5, 2022Corporates help AFH2 reach initial close
Asahi Intecc, Eisai and Ohara were among the LPs of Africa-minded AAIC Investment’s second vehicle, following in the footsteps of corporate-backed Samurai Africa Fund 2.
May 5, 2022Suzuken to seek out corporate venturing deals
The drug wholesaler’s CVC fund will have up to $39.3m in capital, and will be led by Suzuken's head of corporate strategy, Yuichi Yamamoto.
May 4, 2022Daily Deal Round Up: May 3, 2022
Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.
May 3, 2022VisionNav visualises $80m
Meituan co-led the unmanned forklift producer’s series C-plus round, which came seven months after a first close that featured ByteDance and Lenovo.
May 3, 2022Zepto receives $200m series D delivery
Kaiser Permanente backed the India-based rapid delivery challenger as it squares up against bigger rivals.
May 3, 2022Daily Deal Round Up: April 29, 2022
Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.
Apr 29, 2022Temasek takes $162m to Info Edge funds
Info Edge's corporate venturing activities are being boosted by Singapore-owned Temasek, which is committing 50% of the capital for three of its funds.
Apr 29, 2022Daily Deal Round Up: April 28, 2022
Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.
Apr 28, 2022About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


